JP2008504233A5 - - Google Patents

Download PDF

Info

Publication number
JP2008504233A5
JP2008504233A5 JP2007509742A JP2007509742A JP2008504233A5 JP 2008504233 A5 JP2008504233 A5 JP 2008504233A5 JP 2007509742 A JP2007509742 A JP 2007509742A JP 2007509742 A JP2007509742 A JP 2007509742A JP 2008504233 A5 JP2008504233 A5 JP 2008504233A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
heteroaryl
group
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2007509742A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008504233A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/014345 external-priority patent/WO2006076009A2/en
Publication of JP2008504233A publication Critical patent/JP2008504233A/ja
Publication of JP2008504233A5 publication Critical patent/JP2008504233A5/ja
Ceased legal-status Critical Current

Links

JP2007509742A 2004-04-23 2005-04-25 転写因子調節化合物およびその使用法 Ceased JP2008504233A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US56504704P 2004-04-23 2004-04-23
US56903204P 2004-05-07 2004-05-07
US62325104P 2004-10-28 2004-10-28
PCT/US2005/014345 WO2006076009A2 (en) 2004-04-23 2005-04-25 Transcription factor modulating compounds and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2008504233A JP2008504233A (ja) 2008-02-14
JP2008504233A5 true JP2008504233A5 (https=) 2008-06-19

Family

ID=36678027

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007509742A Ceased JP2008504233A (ja) 2004-04-23 2005-04-25 転写因子調節化合物およびその使用法

Country Status (7)

Country Link
US (2) US20060160799A1 (https=)
EP (1) EP1742637A4 (https=)
JP (1) JP2008504233A (https=)
AU (1) AU2005324492B2 (https=)
CA (1) CA2562763A1 (https=)
IL (3) IL178600A0 (https=)
WO (1) WO2006076009A2 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553828B2 (en) 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
US20040106553A1 (en) * 2002-06-24 2004-06-03 Alekshun Michael N. Methods for preventing and treating microbial infections by modulating transcription factors
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
KR20060087386A (ko) * 2005-01-28 2006-08-02 주식회사 대웅제약 신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물
US20090175805A1 (en) * 2006-03-13 2009-07-09 The Trustees Of Columbia University In The City Of New York Neuraminidase Inhibitors and uses thereof
CA2656157A1 (en) * 2006-06-23 2008-10-30 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
WO2008014307A2 (en) * 2006-07-26 2008-01-31 Novartis Ag Inhibitors of undecaprenyl pyrophosphate synthase
EP2089383B1 (en) * 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
CA2681813A1 (en) * 2007-03-27 2009-01-08 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
EP2000140A1 (en) * 2007-06-05 2008-12-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of derivatives of 3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine or of 3-oxo-2,3-dihydro-5H-imidazolo[3,2-a]pyrimidine for the preparation of pharmaceutical compositions intended for the treatment of cancer
TWI580356B (zh) 2007-08-13 2017-05-01 孟山都科技有限責任公司 控制植物寄生性線蟲的化合物及方法以及被覆有該化合物之種子
WO2009026657A1 (en) * 2007-08-29 2009-03-05 The University Of Sydney Flavonoid ppar agonists
US8716283B2 (en) 2007-11-07 2014-05-06 University Of Massachusetts Type III secretion inhibitors, analogs and uses thereof
WO2009061491A2 (en) * 2007-11-07 2009-05-14 University Of Massachusetts Type iii secretion inhibitors and uses thereof
EP2732819B1 (en) * 2008-02-07 2019-10-16 Massachusetts Eye & Ear Infirmary Compounds that enhance Atoh-1 expression
WO2010027762A1 (en) * 2008-09-04 2010-03-11 Boehringer Ingelheim International Gmbh Indolizine inhibitors of leukotriene production
US8647642B2 (en) 2008-09-18 2014-02-11 Aviex Technologies, Llc Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
GB0821913D0 (en) 2008-12-02 2009-01-07 Price & Co Antibacterial compounds
US20110059962A1 (en) * 2009-04-22 2011-03-10 Alekshun Michael N Transcription factor modulating compounds and methods of use thereof
ITPI20090140A1 (it) * 2009-11-09 2011-05-10 Univ Pisa Composto inibitore dell'enzima lattato deidrogenasi (ldh) e composizione farmaceutica che comprende tale composto
MX2012012531A (es) * 2010-04-27 2013-04-03 Astellas Pharma Inc Derivado de imidazo [1, 2-a] piridina.
WO2011151617A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151620A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
ES2568455T3 (es) 2010-06-01 2016-04-29 Summit Therapeutics Plc Compuestos para el tratamiento de enfermedad asociada a Clostridium difficile
WO2011151618A2 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile-associated disease
WO2011151619A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
CN103402988B (zh) 2010-10-25 2015-11-25 范德比尔特大学 用于抑制昆虫宿主感觉的组合物
FR2967353B1 (fr) * 2010-11-16 2013-08-16 Centre Nat Rech Scient Derives de quinolinone
EP3653054A1 (en) * 2011-05-06 2020-05-20 Vanderbilt University Composition for inhibition of insect sensing
CN102887859B (zh) * 2011-07-21 2014-10-29 首都医科大学 一种具有镇痛和抗炎活性的化合物，其制备方法及应用
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
UA115576C2 (uk) 2012-12-06 2017-11-27 Байєр Фарма Акцієнгезелльшафт Похідні бензимідазолу як антагоністи ер4
WO2016127102A2 (en) 2015-02-06 2016-08-11 Ernesto Abel-Santos Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis
US10791739B2 (en) 2015-03-25 2020-10-06 Vanderbilt University Binary compositions as disruptors of orco-mediated odorant sensing
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11576892B2 (en) 2015-08-18 2023-02-14 Novation Pharmaceuticals Inc. Benzopyran derivatives and uses thereof
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2019018562A1 (en) 2017-07-19 2019-01-24 Ideaya Biosciences, Inc. AMIDO COMPOUND AS MODULATORS OF AHR
MX2020002869A (es) 2017-09-15 2020-07-24 Aduro Biotech Inc Compuestos de pirazolopirimidinona y usos de los mismos.
KR102737283B1 (ko) 2019-07-17 2024-12-03 서밋 (옥스포드) 리미티드 리디닐라졸 및 이의 결정 형태의 제조방법
CA3184471A1 (en) * 2020-05-27 2021-12-02 The Penn State Research Foundation Antibacterial compounds
CN116075510A (zh) * 2020-08-19 2023-05-05 百时美施贵宝公司 1H-苯并[d]咪唑衍生物作为TLR9抑制剂用于治疗纤维化
GB202100471D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Preparation of antibacterial compounds
GB202100470D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Solid tablet dosage for of ridinilazole
EP4398890A4 (en) 2021-09-09 2025-07-30 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The Univ Of Nevada Las Ve C. Difficile Spore Germination Inhibitors
US11975009B2 (en) * 2022-05-02 2024-05-07 Znable Llc Use of zinc porphyrin as an antimicrobial
CN119033788B (zh) * 2024-08-27 2025-10-31 南京中医药大学 分枝杆菌硫醇二硫还原酶抑制剂在制备抗分枝杆菌药物中的应用

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3300505A (en) 1964-12-07 1967-01-24 Ciba Geigy Corp Ether-2-r-substituted benzimidazoles and derivatives and acid addition salts thereof
US3429890A (en) 1964-12-31 1969-02-25 Merck & Co Inc Certain 2-thiazolylbenzimidazole-1-oxy derivatives
US3325356A (en) 1965-08-20 1967-06-13 Merck & Co Inc Compositions and method for treating helminthiasis
US3449498A (en) 1965-11-18 1969-06-10 Ciba Geigy Corp Analgesic compositions of a 4-aminoal-kylamino-quinazoline and 1-amino-alkoxybenzimidazole
GB1141936A (en) 1966-03-26 1969-02-05 Shionogi & Co Improvements in or relating to benzimidazole derivatives
US3549754A (en) 1969-04-21 1970-12-22 Merck & Co Inc Combination of 2-substituted benzimidazoles and substituted phenothiazines in the treatment of helminthiasis
DE1923481A1 (de) 1969-05-08 1970-11-12 Hoechst Ag Verfahren zur Herstellung von Amiden und Estern der 1-Hydroxy-benzimidazol-2-carbonsaeure
US3686110A (en) 1970-02-27 1972-08-22 Meuch & Co Inc 1-oxybenzimidazoles
US3646049A (en) 1970-03-05 1972-02-29 Merck & Co Inc Acylaminobenzimidazole derivatives
CA953726A (en) 1970-03-05 1974-08-27 Richard J. Bochis Process for preparing 1,5-substituted or 1,6-substituted benzimidazoles
US3873558A (en) 1970-03-05 1975-03-25 Merck & Co Inc Process for preparing 1,5-substituted or 1,6-substituted benzimidazoles
GB1507059A (en) 1974-09-18 1978-04-12 Univ Australian Purines
US4269846A (en) * 1979-10-29 1981-05-26 Usv Pharmaceutical Corporation Heterocyclic compounds useful as anti-allergy agents
JPH0784462B2 (ja) * 1986-07-25 1995-09-13 日清製粉株式会社 ベンゾイミダゾ−ル誘導体
US4859684A (en) 1986-09-15 1989-08-22 Janssen Pharmaceutica N.V. (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use thereof in treating androgen dependent disorders
NZ221729A (en) 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
DE3828537A1 (de) * 1988-08-23 1990-03-01 Basf Ag Neue n-substituierte benzimidazol-2-carbonsaeureanilide, deren verwendung als lichtschutzmittel, insbesondere polymere und diese anilide enthaltendes organisches material
DE3828535A1 (de) * 1988-08-23 1990-03-08 Basf Ag Benzimidazol-2-carbonsaeureanilide, ihre verwendung als lichtschutzmittel fuer organisches material und mit diesen aniliden stabilisiertes organisches material
DE3828536A1 (de) * 1988-08-23 1990-03-01 Basf Ag 2,6-polyalkylpiperidinsubstituierte benzimidazol-2-carbonsaeureanilide und deren verwendung zum stabilisieren von organischem material
DE3830697A1 (de) 1988-09-09 1990-03-22 Knoll Ag Substituierte phenylacetonitrile zur verwendung als resistenzbrecher
US5342957A (en) 1988-11-29 1994-08-30 Janssen Pharmaceutica N.V. Benzimidazoles useful in treating epithelial disorders
CA2002859C (en) 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
JPH0525140A (ja) 1991-07-22 1993-02-02 Sankyo Co Ltd ベンズイミダゾール誘導体
WO1994005810A1 (en) 1992-08-28 1994-03-17 Trustees Of Tufts College Multiple antibiotic resistance operon assays
NZ270985A (en) 1994-04-29 1997-06-24 Lilly Co Eli Substituted benzimidazole derivatives; medicaments and preparation of medicaments
US5552426A (en) 1994-04-29 1996-09-03 Eli Lilly And Company Methods for treating a physiological disorder associated with β-amyloid peptide
JP2915802B2 (ja) 1994-07-14 1999-07-05 呉羽化学工業株式会社 抗生物質耐性微生物の薬剤感受性増感剤
TW381092B (en) * 1995-07-07 2000-02-01 Otsuka Pharma Co Ltd Novel benzimidazole derivatives for use in treating arteriosclerotic diseases
JP2000516611A (ja) * 1996-08-14 2000-12-12 ワーナー―ランバート・コンパニー Ｍｃｐ―１アンタゴニストとしての２―フェニルベンズイミダゾール誘導体
US5976874A (en) 1996-08-16 1999-11-02 Yale University Phenotypic conversion of drug-resistant bacteria to drug-sensitivity
WO1998017267A1 (en) 1996-10-23 1998-04-30 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
AU6328498A (en) 1997-02-21 1998-09-09 Hybridon, Inc. Oligonucleotides specific for the (marorab) operon
US5942532A (en) 1997-09-05 1999-08-24 Ortho Pharmaceutical Corporation 2-substituted phenyl-benzimidazole antibacterial agents
WO2000012089A1 (en) 1998-08-31 2000-03-09 Merck & Co., Inc. Novel angiogenesis inhibitors
AU4803597A (en) 1997-10-02 1999-04-27 Trustees Of Tufts College Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents
US5972995A (en) 1997-10-16 1999-10-26 Children's Hospital Medical Center Of Northern California Compositions and methods for cystic fibrosis therapy
NZ505002A (en) * 1997-12-10 2001-11-30 Dainippon Ink & Chemicals 1,2,5-oxadiazolyl, 1,2,5-thiadiazolyl or 1,2,3-thiadiazolyl oxime derivatives substituted by another heterocyclic group useful as agricultural chemicals
AU4196199A (en) 1998-05-22 1999-12-13 Tufts University Mara family helix-turn-helix domains and their methods of use
US6162393A (en) 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
US6204264B1 (en) * 1998-09-21 2001-03-20 Shiseido Co., Ltd. Benzimidazole derivative, hair growth promoter and external composition for skin using the same
AU782306B2 (en) 1999-03-03 2005-07-21 Board Of Regents, The University Of Texas System Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
SI1194425T1 (sl) 1999-06-23 2005-12-31 Sanofi Aventis Deutschland Substituirani benzimidazoli
WO2004001058A2 (en) * 2001-05-04 2003-12-31 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
US7405235B2 (en) 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
DE10238002A1 (de) 2002-08-20 2004-03-04 Merck Patent Gmbh Benzimidazolderivate
WO2004041209A2 (en) * 2002-11-01 2004-05-21 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
EP1479676A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Benzimidazole-derivatives as factor xa inhibitors

Similar Documents

Publication Publication Date Title
JP2008504233A5 (https=)
CA2672652A1 (en) Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
RU2003137578A (ru) Производные ароматических дикарбоновых кислот
JP2010090138A5 (https=)
RU2005108046A (ru) 1, 2, 3-триазольные производные, обладающие бактерицидной (например, фунгицидной)активностью
CA2247275A1 (en) Use of rapamycin derivatives in vasculopathies and xenotransplantation
JP2013541514A5 (https=)
TR200103185T2 (tr) MEK enzimleri inhibitörleri olarak kinolin türevleri.
RU2007116119A (ru) Производные циклоспорина, замещенные 3-эфиром и 3-тиоэфиром, для лечения и профилактики инфекционного гепатита с
JP2005501855A5 (https=)
CA2436891A1 (en) Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
JP2011505347A5 (https=)
JP2006506443A5 (https=)
JP2013533253A5 (https=)
NZ507560A (en) Hydroxamic acid derivatives as antibacterials
HUP9801725A1 (hu) Új benzimidazol-, benzoxazol- és benzotiazolszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
YU25201A (sh) Derivati izosorbid mononitrata i njihova upotreba kao vazodilatacionih agensa sa redukovanom tolerancijom
WO2003048134A1 (en) Triazole compound and medicinal use thereof
RU2007135023A (ru) Производные хиназолина, обладающие ингибирующей активностью в отношении тирозинкиназы
JP2002501043A5 (https=)
EG20476A (en) Process for preparing of n,n'- substituted imidodicarboninidic diamides derived from hydroxylamines
JP2004522781A5 (https=)
EP1930021A3 (en) Novel amide derivatives as growth hormone secretagogues
KR880001593A (ko) 4-(아로일아미노)피페리딘부탄아미드 유도체
KR970703306A (ko) 카르바모일 카르복실산 히드라지드 및 진균류에 대한 이들의 용도(Carbamoyl Carboxylic Acid Hydrazides and Their Use Against Fungi)